Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease

被引：22
作者：
Assouan, Deborah [1 ]
Lebon, Delphine [1 ]
Charbonnier, Amandine [1 ]
Royer, Bruno [1 ]
Marolleau, Jean-Pierre [1 ]
Gruson, Berengere [1 ]
机构：
[1] Ctr Hosp Univ Amiens, Hematol, Amiens, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷 / 05期
关键词：
graft-versus-host disease; hematopoietic stem cell transplantation; ruxolitinib; malignant haematology; corticosteroids; TRANSPLANTATION;
D O I：
10.1111/bjh.14679
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：687 / 689
页数：3
相关论文
共 50 条
  • [1] Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
    Teshima, Takanori
    Nagafuji, Koji
    Henzan, Hideho
    Miyamura, Koichi
    Takase, Ken
    Hidaka, Michihiro
    Miyamoto, Toshihiro
    Takenaka, Katsuto
    Akashi, Koichi
    Harada, Mine
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (02) : 253 - 260
  • [2] Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
    Takanori Teshima
    Koji Nagafuji
    Hideho Henzan
    Koichi Miyamura
    Ken Takase
    Michihiro Hidaka
    Toshihiro Miyamoto
    Katsuto Takenaka
    Koichi Akashi
    Mine Harada
    International Journal of Hematology, 2009, 90 : 253 - 260
  • [3] Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease
    Abedin, Sameem M.
    Hamadani, Mehdi
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (05) : 423 - 427
  • [4] Ruxolitinib for the treatment of graft-versus-host disease
    Ali, Haris
    Salhotra, Amandeep
    Modi, Badri
    Nakamura, Ryotaro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (04) : 347 - 359
  • [5] FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
    Przepiorka, Donna
    Luo, Lola
    Subramaniam, Sriram
    Qiu, Junshan
    Gudi, Ramadevi
    Cunningham, Lea C.
    Nie, Lei
    Leong, Ruby
    Ma, Lian
    Sheth, Christopher
    Deisseroth, Albert
    Goldberg, Kirsten B.
    Blumenthal, Gideon M.
    Pazdur, Richard
    ONCOLOGIST, 2020, 25 (02) : E328 - E334
  • [6] Ruxolitinib for the treatment of steroid refractory pediatric chronic graft-versus-host disease
    Belina, Morgan E.
    Driscoll, Timothy A.
    Blanchard, Sarah K.
    Cardones, Adela R.
    PEDIATRIC DERMATOLOGY, 2022, 39 (03) : 432 - 433
  • [7] A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease
    Bhatt, Vijaya Raj
    Shostrom, Valerie K.
    Choe, Hannah K.
    Hamilton, Betty K.
    Gundabolu, Krishna
    Maness, Lori J.
    Kumar, Virender
    Mahato, Ram I.
    Smith, Lynette M.
    Nishihori, Taiga
    Lee, Stephanie J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (33) : 3977 - 3985
  • [8] Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation
    Abedin, Sameem
    McKenna, Edward
    Chhabra, Saurabh
    Pasquini, Marcelo
    Shah, Nirav N.
    Jerkins, James
    Bairn, Arielle
    Runaas, Lyndsey
    Longo, Walter
    Drobyski, William
    Hari, Parameswaran N.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (08) : 1689 - 1694
  • [9] Long-Term Follow-Up of Ruxolitinib in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease
    Ferreira, Aliana Meneses
    Szor, Roberta Shcolnik
    Molla, Vinicius Campos
    Seiwald, Maria Cristina
    de Moraes, Pedro Arruda
    Brito Medeiros da Fonseca, Ana Rita
    Xavier, Erick Menezes
    Serpa, Mariana Gomes
    Tucunduva, Luciana
    Novis, Yana
    Arrais-Rodrigues, Celso
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09): : 777.e1 - 777.e6
  • [10] Daclizumab for children with corticosteroid refractory graft-versus-host disease
    Teachey, DT
    Bickert, B
    Bunin, N
    BONE MARROW TRANSPLANTATION, 2006, 37 (01) : 95 - 99
12345